A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Azienda Ospedaliero-Universitaria di Parma
Numab Therapeutics AG
NuCana plc
Medicenna Therapeutics, Inc.
Checkpoint Therapeutics, Inc.
BerGenBio ASA
Aminex Therapeutics, Inc.
Seagen Inc.
Jules Bordet Institute
Quadriga Biosciences, Inc.
Abramson Cancer Center at Penn Medicine
INSYS Therapeutics Inc
National Institutes of Health Clinical Center (CC)